Why does task performance decrease with burst length? حسب Swathi Anil (17382903)

Madrasin decreases transcription of protein-coding genes. حسب Michael Tellier (8284752)

The process of data collection and annotation by drones. حسب Junyan Wang (4738518)

الموضوعات:

Sensitivity to small changes. حسب Ariel Burman (20329776)

Flow diagram of different experiments and the study process. حسب Omid Mehrpour (9385929)

الموضوعات:

RNA targets and biological process GO terms associated with Mod RiP-Seq analysis. حسب Amalia S. Parra (4173004)

الموضوعات:

Introgression decreases allelic shuffling. حسب Enrique J. Schwarzkopf (6579275)

Larger example of stimuli with cue relevant for Task 3. حسب Marcel F. Hinss (14675457)

Centrifuged FMT products consistently exhibit the lowest median log₁₀ drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the g... حسب Nina K. Randolph (21030732)

Flowchart of the screening process. حسب Huixia Ren (500186)

"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"

The small blue circles show the IC-volume (mean of left and right) from 72 males and the small red squares from 51 females as a function of age. حسب Pingling Kwok (14896191)

Significantly decreased necrosis observed on wheat leaves inoculated with <i>ΔZtknr4</i>. حسب Erika Kroll (20537020)

Flame binarization image processing flow. حسب Lei Bai (631944)

الموضوعات:

Ignition delay process shot by high-speed camera. حسب Lei Bai (631944)

الموضوعات:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات:

Demographic and clinical characteristics of participants at baseline. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study flow chart. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات: